WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark CELULARITY was filed as Word mark on 08/11/2022 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1692918 |
| Countries | 
|
| Base trademark |
No. ,
July 28, 2024
|
| Application date | August 11, 2022 |
| Expiration date | August 11, 2032 |
Trademark owner
170 Park Avenue
Florham Park NJ 07932
US
Florham Park NJ 07932
US
Trademark representatives
1650 Market Street, Suite 2800
Philadelphia PA 19103
US
goods and services
01
Bioengineered cells for use in scientific, laboratory and
medical research; human allograft tissue made from human
umbilical cords and human placentas for use in scientific,
laboratory and medical research
05
Cells and biological preparations intended for medical and
clinical use, namely, blood, stem cells, umbilical cord
cells, umbilical cord blood, and placental allograft tissue;
bioengineered cells for use in immunotherapies for cancer
and other diseases; human allograft tissue made from human
umbilical cords and human placentas intended for subsequent
implantation; human amniotic membrane and human chorionic
membrane intended for subsequent implantation; human
collagen compositions and extracellular matrix compositions
intended for subsequent implantation; biological products
for medical use, namely, placental-derived natural killer
cells, and placental-derived cytotoxic T cells with a
chimeric antigen receptor (CAR) specific for a cancer or
other disease-associated antigen; biological tissue intended
for use as a wound covering; wound dressings; burn
dressings; surgical dressings; pharmaceutical preparations
for wounds; biological products for medical use, namely,
placental-derived cytotoxic T cells with a chimeric antigen
receptor (CAR) specific for a cancer or other
disease-associated antigen
40
Custom manufacturing services of biopharmaceuticals and gene
and cell therapy products, namely, genetically engineered
tissues for others; custom manufacturing services for others
in the fields of mammalian cell banks, plasmids, purified
mitochondria, cell lysates; custom production of cells for
others; custom manufacturing of cells for others; advanced
cell custom manufacturing for others; manufacturing process
consulting
42
Research, development and testing services for others in the
fields of genomics, biotechnology and pharmaceuticals; stem
cell research services; research, development and testing
services in the fields of genomics, biotechnology and
pharmaceuticals, namely, collection, testing, processing,
preservation, storage and retrieval of cells and biological
tissue, namely, blood, stem cells, umbilical cords,
umbilical cord blood, and placental tissue; laboratory
research services in the field of genomics, biotechnology
and pharmaceuticals consisting of collection, testing,
processing, preservation, storage and retrieval of
bioengineered cells, human allograft tissue made from human
umbilical cords and human placentas, human amniotic membrane
and human chorionic membrane, human collagen and
extracellular matrix compositions; technical writing and
providing information via a website in the field of medical
research relating to banking stem cells and cord blood
banking; biological research, namely, biosourcing of
clinically accessible, immune-tolerant human stem and
progenitor and other postpartum placenta-derived cell
populations and tissues for medical research; medical
research to find methods to restore the structure and
function of damaged or diseased tissues and organs,
including wound care, reconstructive medicine, whole organ
and tissue regeneration and renewal; medical research
regarding emergent cell therapies; medical research
regarding allogeneic immunotherapy; providing on-line
information, news and commentary in the field of medical
research relating to the foregoing
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 26, 2023 | 2023/22 Gaz | EM | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 31, 2023 | 2023/14 Gaz | CN | Rejection |
| March 7, 2023 | 2023/10 Gaz | GB | Rejection |
| November 25, 2022 | 2022/49 Gaz | EM | Rejection |
| August 11, 2022 | 2022/42 Gaz | US | Registration |
ID: 141692918